13G Filing: Tappan Street Partners and Peregrine Pharmaceuticals Inc (PPHM)

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13G

Under
the Securities Exchange Act of 1934*

(Amendment
No. 1)

 

Peregrine Pharmaceuticals, Inc.

(Name of Issuer)

Common Stock ($0.001 par value)

(Title of Class of Securities)

713661502

(CUSIP Number)

July 11, 2017

(Date of Event Which Requires Filing of this Statement)

Check
the appropriate box to designate the rule pursuant to which this Schedule is filed:

	☐	Rule 13d-1(b)
	☒	Rule 13d-1(c)
	☐	Rule 13d-1(d)

*
The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to
the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided
in a prior cover page.

The
information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section
18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the Notes).